Showing results (211-220 of 221) with videos related to
Sort By:
Pageof 23
Zeitschrift Fur Gastroenterologie|September 18, 2007
[S3-guidelines for diagnosis and treatment of gallstones. German Society for Digestive and Metabolic Diseases and German Society for Surgery of the Alimentary Tract]F Lammert, M W Neubrand, R Bittner, et al.Alimentary Pharmacology & Therapeutics|November 4, 2015
The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European studyV S Hegade, M Krawczyk, A E Kremer, et al.NPJ Breast Cancer|December 14, 2022
Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cellsG R Hancock, K S Young, D J Hosfield, et al.European Journal of Gynaecological Oncology|April 26, 2018
Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancerY Yildiz, Y Kucukzeybek, A Alacacioglu, et al.Human Molecular Genetics|June 21, 2019
Genomic knockout of alms1 in zebrafish recapitulates Alström syndrome and provides insight into metabolic phenotypesJessica E Nesmith, Timothy L Hostelley, Carmen C Leitch, et al.Alimentary Pharmacology & Therapeutics|September 24, 2017
Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosisG Stirnimann, T Berg, L Spahr, et al.Gut|November 7, 2008
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancyP H Dixon, S W C van Mil, J Chambers, et al.Journal of Viral Hepatitis|October 15, 2013
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infectionA J van der Meer, B J Veldt, J J Feld, et al.European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeM Moehler, A Maderer, C Schimanski, et al.Pageof 23